A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center

Journal of Autoimmunity（2021）

引用 24|浏览44

暂无评分

摘要

•Patients with AI/IMID fwho required admission for SARS CoV2 infection have a lower risk of developing severe disease.•Among patients with AID and IMID, there were no differences in terms of severity.•According to the 7-category ordinal scale, maximum oxygen requirement was lower among AI/IMID group.

查看译文

关键词

Autoimmune diseases,Severe acute respiratory syndrome coronavirus 2,COVID-19,Immunosuppression,Adverse outcome

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要